NeuroSense Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement ...Middle East

CAMBRIDGE, Mass., April 10, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a company developing novel treatments for severe neurodegenerative diseases, today announced it has entered into a securities purchase agreement with a single...

Hence then, the article about neurosense announces pricing of 4 5 million registered direct offering and concurrent private placement was published today ( Thursday 11/04/2024 - 02:25 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NeuroSense Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement )

Also on site :

• What to Know About Allegations of Excessive Drinking by FBI Director Kash Patel
• The Critically Acclaimed 2012 Best-Seller Named the 'Best Novel of the Century': 'Every Word is Finely Tuned'
• 25 Popular Toys Every Kid Wanted in the 1970s